Influence of interdisciplinary and intersectoral clinical pathways on mortality and quality of life of patients with sepsis and sepsis sequelae within the framework of the Comprehensive Sepsis Center Dresden-Kreischa

Not yet recruiting

• Conditions: A41; A40; Other sepsis; Streptococcal sepsis

• Registration Number: DRKS00020495
• Lead Sponsor: Zentrum für fachübergreifende Intensivmedizin und Weaning Klinik Bavaria Kreischa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

All patients with sepsis and sepsis sequelae treated in intensive care at the Clinic and Polyclinic for Anaesthesiology at the University Hospital during the examination period of three years are included in the treatment pathway after consent.

Exclusion Criteria

No sepsis.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality and quality of life (EQ5D) after one year (primary clinical endpoints)

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints are: <br>- proportion of patients requiring inpatient care<br>- Mobility (Functional Ambulation Category, FAC)<br>- Cognition (Montreal Cognitive Assessment, MoCA)<br>- psychological health (Hospital Anxiety and Depression Scale, HADS)<br>